As of 2025-07-14, the EV/EBITDA ratio of Crescita Therapeutics Inc (CTX.TO) is -0.67. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTX.TO's latest enterprise value is 1.40 mil CAD. CTX.TO's TTM EBITDA according to its financial statements is -2.10 mil CAD. Dividing these 2 quantities gives us the above CTX.TO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 0.7x - 9.2x | 0.9x |
| Forward P/E multiples | 0.5x - 10.8x | 0.6x |
| Fair Price | 0.33 - (0.61) | 0.33 |
| Upside | -31.6% - -225.5% | -32.3% |
| Date | EV/EBITDA |
| 2025-07-09 | -0.67 |
| 2025-07-08 | -0.67 |
| 2025-07-07 | -0.67 |
| 2025-07-02 | -0.67 |
| 2025-06-30 | -0.76 |
| 2025-06-27 | -0.76 |
| 2025-06-25 | -0.71 |
| 2025-06-24 | -0.67 |
| 2025-06-20 | -0.67 |
| 2025-06-19 | -0.67 |
| 2025-06-18 | -0.89 |
| 2025-06-11 | -0.80 |
| 2025-06-10 | -0.62 |
| 2025-06-09 | -0.62 |
| 2025-06-06 | -0.53 |
| 2025-06-05 | -1.16 |
| 2025-06-04 | -1.07 |
| 2025-06-03 | -1.07 |
| 2025-06-02 | -0.98 |
| 2025-05-30 | -0.80 |
| 2025-05-28 | -0.80 |
| 2025-05-27 | -0.89 |
| 2025-05-26 | -1.16 |
| 2025-05-23 | -1.16 |
| 2025-05-22 | -1.16 |
| 2025-05-21 | -1.16 |
| 2025-05-20 | -1.16 |
| 2025-05-15 | -0.89 |
| 2025-05-14 | -0.98 |
| 2025-05-13 | -1.07 |
| 2025-05-12 | -1.25 |
| 2025-05-07 | -1.34 |
| 2025-05-06 | -1.52 |
| 2025-05-05 | -1.25 |
| 2025-05-02 | -1.52 |
| 2025-04-30 | -1.52 |
| 2025-04-29 | -1.52 |
| 2025-04-28 | -1.52 |
| 2025-04-24 | -1.43 |
| 2025-04-22 | -1.43 |
| 2025-04-21 | -1.34 |
| 2025-04-16 | -1.61 |
| 2025-04-15 | -1.71 |